NCT00779922
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +20 more
- Locations
-
- Poitiers University Hospital Poitiers, France
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
NCT00784927
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +26 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00900263
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
- Highlands Oncology Group - Springdale Bentonville, Arkansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
NCT01580371
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- ASAN Medical Center Seoul, South Korea
NCT00700531
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Cast Nephropathy, +21 more
- Locations
-
- University Hospital Birmingham Birmingham, West Midlands, United Kingdom
NCT02917239
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
NCT01457417
- Conditions
- Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +23 more
- Locations
-
- Scottsdale Healthcare Scottsdale, Arizona, United States
- New York Oncology Hematology, P.C. Albany, New York, United States
- Greenville Hospital System University Medical Center Greenville, South Carolina, United States
- Texas Oncology - Baylor, Charles A. Sammonds Cancer Center Dallas, Texas, United States
Completed
A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
NCT02116569
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Nagoya, Japan
- Tokyo, Japan
NCT00580372
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States
NCT01362972
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified